Research on the virtues of resveratrol
Nau, J.-Y.
Revue Medicale Suisse 6(263): 1790-1791
2010
ISSN/ISBN: 1660-9379 PMID: 20963966 Document Number: 646681
Document emailed within 1 workday
Related Documents
Giardina, S.; Michelotti, A.; Zavattini, G.; Finzi, S.; Ghisalberti, C.; Marzatico, F. 2010: Efficacy study in vitro: assessment of the properties of resveratrol and resveratrol + N-acetyl-cysteine on proliferation and inhibition of collagen activity Minerva Ginecologica 62(3): 195-201Gennaro, V.; Ricci, P.; Levis, A.G.; Crosignani, P. 2009: Epidemiology's and epidemiologists' vices and virtues Epidemiologia e Prevenzione 33(4-5 Suppl 2: 49-56
Larkin, G.Luke. 2008: Deadly sins and cardinal virtues in the clinical management of intimate partner violence Journal of Clinical Ethics 19(4): 334-345
van Dam, P.A.; Watson, J.V.; Lowe, D.G.; Shepherd, J.H. 1992: Flow cytometric measurement of cell components other than DNA: virtues, limitations, and applications in gynecologic oncology Obstetrics and Gynecology 79(4): 616-621
Reilly, M. 1977: A response to: defining occupational therapy: the meaning of therapy and the virtues of occupation American Journal of Occupational Therapy: Official Publication of the American Occupational Therapy Association 31(10): 673-674
Orgován, G.áb.; Noszál, B.él. 2015: Resveratrol in Pharmaceutical Chemistry Acta Pharmaceutica Hungarica 85(4): 123-129
Goldberg, D.M. 1996: More on antioxidant activity of resveratrol in red wine Clinical Chemistry 42(1): 113-114
Bradamante, S.; Piccinini, F.; Barenghi, L.; Bertelli, A.A.; De Jonge, R.; Beemster, P.; De Jong, J.W. 2000: Does resveratrol induce pharmacological preconditioning? International Journal of Tissue Reactions 22(1): 1-4
Taubert, D.; Berkels, R. 2003: Upregulation and activation of eNOS by resveratrol Circulation 107(11): E78
Braeuning, A. 2014: Does resveratrol inhibit NF-kappaB activity? Die Pharmazie 69(1): 54
Lin, J.K.; Tsai, S.H. 1999: Chemoprevention of cancer and cardiovascular disease by resveratrol Proceedings of the National Science Council Republic of China. Part B Life Sciences 23(3): 99-106
Xiao, Y.; Chen, H.; Song, C.; Zeng, X.; Zheng, Q.; Zhang, Y.; Lei, X.; Zheng, X. 2015: Pharmacological activities and structure-modification of resveratrol analogues Die Pharmazie 70(12): 765-771
Bobrowska-Hägerstrand, M.; Lillås, M.; Mrówczyñska, L.; Wróbel, A.; Shirataki, Y.; Motohashi, N.; Hägerstrand, H. 2006: Resveratrol oligomers are potent MRP1 transport inhibitors Anticancer Research 26(3a): 2081-2084
Shen, Y.; Xu, J. 2019: Resveratrol Exerts Therapeutic Effects on Mice with Atopic Dermatitis Wounds: a Compendium of Clinical Research and Practice 31(11): 279-284
Liu, L.; Zhang, Y.; Zhu, K.; Song, L.; Tao, M.; Huang, P.; Pan, Y. 2018: Resveratrol inhibits glioma cell growth via targeting LRIG1 Journal of BUON: Official Journal of the Balkan Union of Oncology 23(2): 403-409
Farghali, H.; Kameníková, L. 2017: Targeted drug delivery system: potential application to resveratrol Ceska a Slovenska farmacie: casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti 66(2): 76-82
Rubiolo, J.A.; López-Alonso, H.; Martín-Vázquez, V.; Fol-Rodríguéz, N.M.; Vieytes, M.R.; Botana, L.M.; Vega, F.V. 2012: Resveratrol inhibits proliferation of primary rat hepatocytes in G0/G1 by inhibiting DNA synthesis Folia Biologica 58(4): 166-172
Han, Y.; Cheng, L.; Dai, Y. 1999: Determination of resveratrol in grape wine by high performance liquid chromatography Se Pu 17(4): 366-368
Li, J.-f.; Gao, M.-y.; Wang, H.-m.; Liu, Q.-y.; Mao, S.-r. 2015: Optimization and in vitro characterization of resveratrol-loaded poloxamer 403/407 mixed micelles Yao Xue Xue Bao 50(8): 1045-1051
Bertelli, A.A.; Giovannini, L.; Stradi, R.; Urien, S.; Tillement, J.P.; Bertelli, A. 1996: Kinetics of trans- and cis-resveratrol (3,4',5-trihydroxystilbene) after red wine oral administration in rats International Journal of Clinical Pharmacology Research 16(4-5): 77-81